Apparatus and method for identifying a target region

The system uses fluid pressure and pulsatile waveform detection to improve the accuracy of needle placement by distinguishing between false and true loss of resistance, enhancing safety and reliability in anatomical procedures.

JP7593649B2Active Publication Date: 2024-12-03MILESTONE SCIENTIFIC INC
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2021568531
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-05-16
Filing Date
2020-03-16
Publication Date
2024-12-03
Estimated Expiration
2040-03-16

AI Technical Summary

Technical Problem

Existing methods for locating anatomical targets, such as the epidural space, suffer from false loss of resistance (LOR) during needle insertion, leading to inaccurate placement and potential complications like overinjection or accidental spinal puncture.

Method used

A system with a sensor to detect fluid pressure and pulsatile waveforms, combined with a controller to analyze pressure data, providing visual and auditory feedback to guide needle placement accurately.

Benefits of technology

Enhances the reliability and safety of needle insertion by distinguishing between false and true loss of resistance, reducing complications and ensuring precise placement of needles in anatomical targets.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007593649000001
    Figure 0007593649000001
  • Figure 0007593649000002
    Figure 0007593649000002
  • Figure 0007593649000003
    Figure 0007593649000003
Patent Text Reader

Abstract

A method and apparatus for use in locating a target region within a subject's body, for example for drug delivery, is provided. The system includes an assembly for controlling the flow of fluid from a fluid reservoir to a conduit, such as a needle. A sensor detects a characteristic indicative of fluid pressure within the conduit. The system processes data from the sensor to detect the presence of a pulsatile waveform. A controller controls operation of the system based on the presence and amplitude of the pulsatile waveform.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] Related Applications This application claims priority to U.S. Patent Application No. 16 / 414,499, filed May 16, 2019, the entire contents of which are incorporated herein by reference.

[0002] The present invention relates to methods and devices used to locate target areas within a subject's body, for example for drug delivery purposes. [Background technology]

[0003] Locating a target area within the body, such as an anatomical cavity within a patient's body, is particularly important in providing anesthesia, biopsy, or aspiration of material from the cavity.

[0004] For example, blocking the epidural tissue space with local anesthesia has been found to produce a temporary loss of sensation in the lower extremities of the body. Such local anesthesia can be effectively used in many invasive procedures requiring anesthesia of the lower body, including, but not limited to, childbirth, hip replacement surgery, and a variety of other surgical procedures. Such local anesthesia can also be effectively used to treat chronic and acute "back pain" caused by, for example, spinal disease and compression of the spinal accessory nerve. To achieve effective local anesthesia to block nerve transmission to the central nervous system, an appropriate amount of local anesthetic liquid must be administered within an anatomical location in close proximity to the spinal cord at a specific level of the spinal column, known as the epidural space.

[0005] The epidural space is that portion of the spinal canal that is not occupied by the dura mater and its contents. It lies between the dura mater and the endosteum within the spinal canal and extends from the foramen magnum to the sacral hiatus. The anterior and posterior nerve roots within the dura mater run across the epidural space and join at the intervertebral bodies and discs. In lateral view, the epidural space is adjacent to the periosteum of the pedicles and the intervertebral foramina. In posterior view, the adjacent structures are the anterior periosteum of the lamina, the articular processes and their ligaments, the periosteum of the vertebral roots, and the interlaminar space filled by the ligamentum flavum. The epidural space contains a venous plexus and adipose tissue of a similar quality to that of the fat in the paravertebral spaces.

[0006] The fluid-filled epidural space (posterior epidural space) is a confined anatomical region with an irregular shape of a few square millimeters relative to the cross-section of the vertebrae and spinal column. This fluid-filled space is very narrow and intimately associated with the dura of the spine and adjacent to the ligamentum flavum. Therefore, it is necessary to identify this fluid-filled space reliably because the dura would be punctured if the needle bevel or tip were to continue penetration after protruding from the ligamentum flavum. The loss of resistance (LOR) technique has been employed as a standard technique for locating the fluid-filled epidural space. This technique utilizes a low-friction plastic or glass syringe connected to an epidural Touhy needle (16-18 gauge). Additionally, pump-driven systems have been developed to identify the epidural space, where pressure is monitored using visual and acoustic representations of the fluid pressure within the system or tip of the needle.

[0007] When utilizing the loss of resistance (LOR) technique, the needle is advanced until the clinician's subjective "feeling of resistance" is a distinct backpressure against the plunger. The clinician must identify the location of the ligamentum flavum anatomy by subjectively distinguishing the backpressure or resistance encountered. After penetrating the ligamentum flavum, the tip of the needle enters the fluid-filled epidural space, thereby identifying true loss of resistance.

[0008] Pressure drops or false LORs are often identified by the operator while advancing the needle into tissue. Such false LORs can be caused by the needle tip entering low density tissue structures such as vacuoles (adipose tissue) or anatomical structures where the tissue is highly distensible such as interspinous tissue. Multiple repositionings of the needle (anterior and posterior) are performed as the needle comes into contact with bony vertebrae while searching for the correct path to the epidural space. Any backward movement (retraction) along the given path during needle repositioning can cause a pressure drop in the fluid, resulting in a false LOR, which further complicates the detection of a true LOR.

[0009] False loss of resistance (LOR) can occur due to a variety of conditions, which can lead to many problems. For example, while attempting to determine the location of the epidural space, fluid may be indiscriminately overinjected, further complicating the identification of the epidural space by releasing excess fluid into the tissue. Furthermore, if the physician has difficulty distinguishing between false and true loss of resistance (LOR), the Tuohy needle may travel beyond the borders of the epidural space and inadvertently advance to the spinal dura, penetrating it, resulting in a wet-tap that can have long-term and dangerous effects on the patient.

[0010] It would therefore be desirable to provide a system that complements or replaces information regarding loss of resistance to accurately guide the needle during needle insertion. The prior art documents relevant to the invention of this application are as follows (including documents cited during the international phase after the international filing date and documents cited when the application entered the national phase in other countries). (Prior art document) (Patent Documents) (Patent Document 1) U.S. Patent Application Publication No. 2006 / 0122555 (Patent Document 2) U.S. Patent Application Publication No. 2014 / 0066891 (Patent Document 3) U.S. Patent No. 5,178,603 (Patent Document 4) U.S. Patent Application Publication No. 2012 / 0296176 (Patent Document 5) U.S. Patent Application Publication No. 2007 / 0197922 (Patent Document 6) International Publication No. 2018 / 204668 Summary of the Invention [Means for solving the problem]

[0011] The present invention provides methods and devices that allow a physician to more easily identify anatomical target regions, such as the epidural space.

[0012] The present invention provides a novel system for guiding a needle to an anatomical target area that provides software logic and apparatus that allows for simplified discrimination between false and true loss of resistance (LOR) when performing procedures such as detecting the epidural space, thereby improving the reliability and safety of such injections.

[0013] According to a first aspect, the present invention provides a device for administering a liquid to a target location within a mammalian subject, the device comprising a needle. The device includes a liquid reservoir for storing liquid to be delivered to the needle, a discharge element movable relative to the liquid reservoir to drive liquid from the liquid reservoir, and a drive element configured to engage and control movement of the discharge element. A controller is also provided for controlling the drive element to control the flow of liquid from the liquid reservoir to the needle. The device further includes a sensor for detecting a characteristic indicative of a liquid pressure within the needle. The sensor is configured to continuously detect the characteristic while the device is inserted within the subject. A flexible conduit is in liquid communication with the liquid reservoir and the sensor, the flexible conduit being substantially rigid in a radial direction. The controller periodically interrupts operation of the drive element and processes data from the sensor to detect one or more characteristics indicative of a pulsatile waveform. Further, the flexible conduit, the liquid reservoir, the ejection element, and the drive element are configured to maintain a substantially constant volume of liquid between the needle and the liquid reservoir, thereby allowing the sensor to accurately detect a pulsatile waveform passing through residual liquid within the needle when the drive element is deactivated. Optionally, the liquid reservoir is a barrel of a syringe. Further, the ejection element is slidably movable within the liquid reservoir.

[0014] In a further aspect, the invention relates to a controller configured to analyze data from the sensor to detect one or more characteristics indicative of loss of resistance.

[0015] According to yet another aspect, the invention provides a system in which the controller interrupts operation of the drive element in response to detecting one or more features, and processes data from the sensor to detect one or more features indicative of a pulsatile waveform. Optionally, the controller may be configured to provide a verification signal indicating that the needle is properly positioned adjacent target tissue upon receiving a signal at the needle indicative of loss of resistance and a signal indicative of the presence of a pulsatile waveform.

[0016] According to yet another aspect, the invention includes a display including a first output configured to display fluid pressure at the needle as a function of time in a manner consistent with a loss of resistance guidance procedure. Additionally, the controller is configured to process data from the sensor to isolate data representative of a pulsatile waveform. The display can have a second output configured to display data representative of a pulsatile waveform while the first output displays fluid pressure as a function of time in a first portion.

[0017] The present invention also provides a method for locating a target area in a subject's body with a needle in fluid communication with a reservoir. The method includes providing a reservoir containing an infusate and a tube connected to the reservoir at one end and the needle at the other end for insertion into the subject's body, and acquiring data relating to a resistance measurement of the infusate as the infusate is injected through the needle and into the subject's body. The method further includes advancing the needle into the subject. The method further includes injecting the infusate into the subject during the advancing step. The method further includes intermittently interrupting the steps of advancing the needle and injecting the infusate. The present invention also includes acquiring data relating to fluid pressure in the needle during the intermittently interrupting steps, and processing the data relating to fluid pressure acquired during the intermittently interrupting steps to detect one or more features indicative of a pulsatile waveform at the needle.

[0018] Optionally, another aspect of the invention includes resuming the steps of advancing the needle and injecting the infusion fluid after the step of intermittently pausing.

[0019] Yet another aspect includes processing data related to fluid pressure in the needle to remove noise associated with fluid flow as the infusion fluid is injected into the subject's body, wherein a pump is operable to inject the infusion fluid during the step of injecting the infusion fluid, and the step of removing noise includes operating the pump prior to inserting the needle into the subject's body and acquiring data related to noise during the step of operating the pump. The step of removing noise may further include modifying the data related to fluid pressure in response to the acquired data related to noise.

[0020] In another aspect, the present invention provides a method that includes selectively varying the amplitude range of hydraulic processing data to attempt to identify a pulsatile waveform.

[0021] Yet another aspect of the invention provides a method of inserting a needle into a patient's body, the method including performing a loss of resistance procedure to attempt to position a needle at a target location within the patient's body, the method including the steps of inserting a needle into the patient's body, injecting a fluid through the needle during the inserting step, detecting fluid pressure in the needle during the injecting step, and guiding the needle in response to detecting fluid pressure. The presence of a pulsatile waveform in the needle is detected, the steps including detecting fluid pressure in the needle when the needle is substantially stationary within the patient's body, and injecting a bolus of drug after performing the loss of resistance procedure indicates the needle is at the target location and detecting the presence of a pulsatile waveform indicates the presence of a pulsatile waveform.

[0022] Optionally, the invention includes intermittently alternating between performing the loss of resistance procedure and detecting the presence of the pulsatile waveform. The step of injecting fluid further comprises electronically controlling a driver to dispense fluid from a fluid reservoir. The step of injecting fluid further comprises electronically controlling the driver in response to detecting the fluid pressure.

[0023] Yet another aspect of the invention is an apparatus for locating a target region, which is an anatomical space located within a subject's body. The apparatus includes a reservoir for receiving an infusion fluid, a needle in fluid communication with the reservoir, and a sensor operable to detect a characteristic indicative of fluid pressure within the needle. A pump is configured to infuse fluid from the reservoir into the needle, and a controller is operable to process data from the sensor relating to fluid pressure within the needle. The controller is configured to process the data from the sensor when the needle is in a resting state to identify a pulsatile waveform. The controller is further configured to provide a signal to guide insertion of the needle, the signal being provided in response to the data from the sensor. The apparatus further includes an input mechanism for selectively varying an amplitude range of the processed data to identify a pulsatile waveform.

[0024] These and other embodiments will now be described in more detail. The various novel features which characterize the invention are pointed out with particularity in the appended claims, which form a part of this disclosure. For a better understanding of the invention, its advantages in operation, and specific objects attained by the use of the same, reference is made to the accompanying drawings and descriptive matter which illustrate preferred embodiments of the invention. [Brief description of the drawings]

[0025] [Figure 1] FIG. 1 is a plan view of a computer-controlled drug delivery system. [Diagram 2] FIG. 2 is a plan view of the drug delivery system of FIG. 1 with a disposable injection assembly connected thereto. [Diagram 3] FIG. 3 is a schematic diagram of the computer-controlled drug delivery system of FIG. [Figure 4A] FIG. 4A is a diagram of a display screen of the system of FIG. 1 showing hydraulic pressure measurements detected by the system. [Figure 4B] FIG. 4B is a diagram showing different amplitude ranges on the display screen of FIG. 4A. [Figure 4C] FIG. 4C is a diagram showing different amplitude ranges on the display screen of FIG. 4B. [Figure 4D] FIG. 4D is a diagram showing different amplitude ranges on the display screen of FIG. 4B. [Figure 5A] FIG. 5A is a diagram of a display screen of the system of FIG. [Figure 5B] FIG. 5B is a diagram showing different amplitude ranges on the display screen of FIG. 5A. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0026] Although the method and apparatus are illustratively described herein in several embodiments and figures, those skilled in the art will recognize that the method and apparatus for sorting articles using a dynamically reconfigurable sorting array is not limited to the described embodiments and figures. It should be understood that the figures and their detailed description are not intended to limit the embodiments to the particular forms disclosed. Rather, they are intended to encompass all modifications, equivalents, and alternatives within the spirit and scope of the method and apparatus for detecting pulsatile waveforms and utilizing the detected pulsatile waveforms to guide or verify placement of a needle or other conduit. Any headings used herein are for organizational purposes only and are not meant to limit the scope of the description and claims herein. As used herein, the word "may" is used in a permissive sense (i.e., may) rather than in a mandatory sense (i.e., must). Similarly, "include," "including," and "includes" mean "including," but are not limited to.

[0027] Referring generally to the drawings, and particularly to Figures 1-3, a drug injection system is generally indicated at 10. System 10 includes an injection assembly 20 and a computer controlled drug delivery device 50, referred to as a driver. Injection assembly 20 includes an insertion needle 24 configured for insertion into a mammalian subject. Injection assembly 20 is connected to driver 50 which, in use, controls fluid flow to the injection assembly. System 10 also includes one or more output mechanisms that provide data to a medical professional during a procedure to assist with proper placement of the needle within the subject's body.

[0028] The system 10 allows a physician to accurately identify target tissue. The system 10 is particularly configured to be used to identify the location of injection of a drug while limiting the administration of the drug to non-target tissue. Such location of injection may occur during both diagnostic and therapeutic procedures. Following needle / catheter placement, the system 10 utilizes the hydraulic pressure of the fluid as it exits the needle or catheter to identify and monitor needle / catheter placement accuracy during injection or aspiration. The system 10 may use a constant low flow rate. In this embodiment, a low flow rate is defined as a constant flow rate between 0.01 mL / sec and 0.20 mL / sec. The constant flow rate maintains a constant column of fluid that allows for a substantially immediate response to pressure changes within the detected tissue. For subjects and therapeutic interventions, a flow rate between 0.005 cc / sec and 0.20 cc / sec is generally appropriate, with 0.01 cc / sec and 0.15 cc / sec being preferred.

[0029] As described further below, the system is configured to identify proper placement of the needle according to various criteria. For example, the system may utilize a loss of resistance technique to identify a space, such as the epidural space. Additionally, the system 10 may be configured to identify the target tissue based on identifying a pulsatile waveform. In this manner, the system may utilize a first search criterion to identify that the needle is properly placed and may further utilize a second search criterion, such as identifying a pulsatile waveform, to verify or validate that the needle is properly placed relative to the target tissue.

[0030] The range of flow rates provided by the driver 50 during needle placement is a range capable of providing responsiveness to rapidly detected pressure changes. The system 10 further includes one or more output mechanisms that provide audible and / or visual feedback of the fluid pressure detected within the insertion needle. This feedback is used by the operator as a means of guidance during insertion needle placement. As shown in FIG. 2, the first output mechanism may be a video display screen, such as an LCD display, that displays data to assist the operator. Additionally, a second output mechanism may be provided. For example, the second output mechanism may be a speaker 84 that provides an output signal.

[0031] Injection Assembly 2, the system 10 includes an injection assembly 20 that is cooperable with a driver 50 during a drug injection procedure. The injection assembly includes a syringe 18, a handpiece or needle 24, and a fluid line 22 that connects the syringe to the handpiece.

[0032] Various elements of the injection assembly, such as the syringe 18, the fluid line 22, and the needle 24, can be disposable. Alternatively, these elements can be reusable. Thus, the various elements of the injection assembly are releasably connected. For example, the fluid line 22 can include a fluid connector at each end. The fluid-tight connectors can be any of a variety of types of connectors. A luer connector is one such connector. At a first end, the fluid connector sealably connects with the syringe, and at a second end, the fluid line sealably connects with the needle 24. Alternatively, the fluid line 22 can be fixedly connected to the rear end of the needle 24. In either embodiment, the needle 24 and the syringe are in fluid communication to provide fluid flow from the syringe to the needle.

[0033] Syringe 18 may be any of a variety of types of hypodermic syringes and may be of different sizes depending on the intended use. Syringe 18 includes a barrel that holds a quantity of medication and a plunger 19 that is slidable within the barrel to move liquid into and out of the barrel. Syringe 18 also preferably includes a flange that projects outwardly from the barrel. This flange functions as a finger flange to facilitate movement of the plunger into the barrel.

[0034] The injection assembly 20 also includes a pressure sensor 20 that detects the fluid pressure therein. The pressure sensor is located at one of a number of locations to measure a pressure that correlates to the fluid pressure at the tip of the needle 24. Alternatively, rather than or in addition to an in-line pressure sensor, the pressure sensor may be a force sensor located within or connected to a thumb plate that drives the syringe plunger 58, or within the driver 50 and measuring the pressure applied to the syringe plunger. Such a force sensor detects the force required to inject the fluid, which is related to the fluid pressure inside the needle. With such a sensor, the detected force is converted to a pressure value that is calculated by the processor. In this embodiment, the pressure sensor 20 is an in-line fluid pressure sensor mounted between the syringe and the tube 22. In this manner, the pressure sensor 20 senses the fluid pressure as the fluid flows out of the syringe and into the tube 22 to which the insertion needle 24 is connected. Similarly, an in-line pressure sensor may be located between the tube and the needle. As shown in FIG. 2, the insertion needle 24 is connected to the front end of the handpiece and the tubing 22 is connected to the rear end of the handpiece.

[0035] Tube 22 comprises an elongated polymeric tube that is sufficiently flexible longitudinally to allow bending during use, but has a thick wall that is rigid so that it does not expand radially substantially, particularly at pressures below 500 mm / Hg, where the tube remains radially rigid.

[0036] The injection assembly 20 can be manually operated to inject the liquid. However, in this embodiment, the flow of liquid from the injection assembly is controlled by a computer-controlled drug delivery system 50, as described in more detail below. The pressure sensor 20 is connected to the drug delivery system 50 by an electrical cable, so that the drug delivery system 50 can monitor and, if desired, vary the flow of liquid in response to data from the pressure sensor 20. The pressure transducer 20 can be connected in-line between the front end of the barrel of the syringe 18 and the first end of the tube 22. One connection for connecting the pressure transducer 20 to the tip of the syringe is a luer connection (although other connections can be used). Such a connection can be secured by a threaded connection and / or a non-reversible connection such as a luer lock. Alternatively, the pressure transducer 20 can be permanently secured by plastic welding or chemical bonding, such as with an adhesive. In this manner, the instantaneous and actual fluid pressure in the drug delivery line 22 is sensed and used by the instrument to provide an approximation of the instantaneous and actual fluid pressure at the tip of the needle 24, i.e., at the site on the patient's body where the needle tip is located. The electronic pressure transducer 20 provides pressure data via an electronic data cable which connects directly to a central unit 50 which collects the pressure measurements.

[0037] The electronic pressure transducer 20 may be any of a variety of pressure sensors, one such sensor being a piezoelectric pressure sensor such as the Meritrans® Pressure Transducer, item MER212, available from Merit Medical Systems, Inc.

[0038] Automated Liquid Delivery System As mentioned above, system 10 includes a fluid delivery system 50 that provides a controlled flow of medication to infusion assembly 20. The fluid delivery system is preferably an automated system, and in this embodiment is a computer-controlled fluid delivery system, referred to as driver 50.

[0039] 1-3, the driver 50 is designed to operate in association with an injection element, such as a syringe 18. The driver 50 includes a cradle 56 configured to receive the syringe 18 and a clamp to hold the syringe within the cradle. The driver 50 includes a drive element 58 operable to drive a plunger in the syringe to flush the liquid from the syringe. The driver 50 controls the movement of the drive element 58 to control the flushing of the liquid from the syringe. In this embodiment, the drive element includes a motor 70 that drives an arm 58 having a clamp with a plurality of fingers that releasably engage the plunger 19. The cradle 56 includes a groove that receives the syringe and is configured to restrain the syringe against longitudinal movement. For example, the cradle 56 includes a slot that receives a flange that projects radially outward from a surface of the barrel of the syringe. Thus, driving the motor in a first direction drives the arm 58 forward to advance the plunger, but because the syringe barrel is fixed in relative axial position, the plunger moves relative to the barrel to expel liquid. The drive CPU provides signals to the motor to control its operation.

[0040] The driver 50 is operable to provide a constant or variable fluid flow. In this embodiment, the driver provides a constant fluid flow in response to a signal from the electronic pressure transducer 20, which continuously senses the fluid pressure during the insertion / injection procedure. Based on a predetermined pressure, the driver 50 stops the fluid flow if the detected pressure exceeds a predetermined threshold. The predetermined threshold may be set by the clinician and stored in the memory 80 of the microprocessor or computer 82, which is the electronics in the driver 50. Similarly, based on the predetermined pressure, the fluid flow is resumed if the fluid pressure falls below the predetermined pressure and continues as long as the pressure remains below the threshold. The same pressure can be used to control the stopping and resuming of the fluid flow. In such a case, the pressure increases to a predetermined level as the fluid flows into the tissue, and then the fluid is stopped until the pressure again falls below the predetermined level. When the pressure falls below the predetermined level, the fluid flow is resumed and maintained constant. In this manner, the fluid flow is started and stopped during the procedure, and the fluid flow is interrupted when a particular predefined pressure is detected.

[0041] The system may include predefined pressure thresholds used to control the flow of drug from the syringe 18 during a procedure. This allows the clinician to selectively inject drugs into specific locations and target tissues for diagnostic and therapeutic procedures. A preselected maximum allowable pressure limit and / or flow rate limit is stored in memory 80, which defines either a recommended maximum pressure or other criteria. When the pressure approaches this limit, a visual and / or audible alarm is generated for the clinician on the screen 62 or via speaker 84, activated by data from the microprocessor 82. Additionally, data recording the entire injection process is stored in memory 80 for future analysis.

[0042] System 10 can directly measure the fluid pressure within injection assembly 20 or can measure a characteristic indicative of the fluid pressure within injection assembly 20. For example, pressure can be measured by detecting a measured pressure resistance during injection. The measured pressure resistance is converted into a visual signal continuously during the insertion procedure. The drug flow rate during the insertion procedure is based on the fluid pressure detected in real time during the procedure. Thus, the drug flow rate is considered to be variable and dependent on the pressure within the system. As such, fluid pressure is the primary control variable in the system.

[0043] One feature of the system is the ability to detect minute pressure changes at the needle tip as the needle is placed in the patient's tissue. One feature that facilitates the detection of minute pressure changes is the constant flow of liquid into the tissue under controlled conditions, which allows for identification and avoidance of undesirable locations based on pressure in the tissue. The system detects these minute pressure changes in real time and dynamically when a constant flow rate of liquid is used. This constant flow rate can be coordinated with a predetermined maximum pressure used in the system to stop the flow of liquid at a predetermined pressure limit to avoid damage to the tissue. With a constant flow rate of liquid, the needle head pressure provides the resistance required in the tissue to detect minute changes in tissue density and compliance in a substantially immediate manner.

[0044] Another aspect that facilitates detection of small pressure changes is precise control of the volume of fluid in the infusion set 18. In particular, the tube 22 of the injection assembly 20 is substantially radially rigid such that the tube does not expand radially at pressures below 500 mm / Hg. Thus, the tube does not expand or swell under any back pressure that may reasonably be expected during use of the injection assembly 20, and therefore does not increase in volume due to any back pressure on the injection assembly. Additionally, the driver 50 precisely controls the position of the plunger relative to the barrel of the syringe to precisely control the volume of fluid within the barrel. In particular, the driver 50 controls the position of the plunger to maintain the plunger in a fixed position against forward or backward movement of the plunger when the driver motor is stopped. In this manner, the driver inhibits or prevents movement of the plunger in response to back pressure of fluid. Under normal operating conditions of the system, the driver maintains the plunger in a fixed position against any back pressure that may reasonably be expected during use of the system. In this manner, when the motor is stopped, the driver acts as a stop preventing relative movement of the plunger with respect to the barrel. This mechanical element, in combination with the rigidity characteristics of the materials used in the assembly 20, prevents deformation at pressures below 500 mm / Hg that may prevent the sensor 20 from detecting small changes in pressure in the fluid. In particular, when the driver is stopped, the configuration of the injection assembly 20 and driver prevents changes in fluid volume that would affect detection of a pulsatile waveform.

[0045] Thus, the flow rate becomes another variable that can be adjusted within a predetermined range to maintain a desired liquid flow. In one particular embodiment, if the pressure exceeds a predetermined threshold (maximum pressure), the liquid flow is stopped. A second variable, the flow rate, may be limited to prevent the liquid from being injected too quickly under low pressure conditions. The relationship between pressure and flow rate is considered to be binary or continuous. A binary relationship exists when the infusion device is configured to deliver liquid at a single, predetermined flow rate at any pressure below a preset maximum pressure. That is, the liquid flow is turned on or off based on whether the pressure exceeds a predetermined threshold. Alternatively, the flow rate can be adjusted as a function of pressure. In this case, the flow rate is reduced when the maximum pressure is reached and increased when the pressure drops. Optionally, the flow rate may be limited at a first preset maximum pressure and resumed at a second, different preset pressure.

[0046] As mentioned above, the system 10 can include a mechanism for displaying relevant infusion data, including, for example, real-time flow rate, pressure, and infusion volume, on the screen 30 of the drive device 50. Similarly, the system can include a mechanism for recording the above information for post-procedure analysis. For example, the system can include a non-volatile electronic storage medium, such as a hard drive, flash drive, optical drive, or other medium for storing electronic data.

[0047] All measurements and information are presented to the clinician in real time, allowing the clinician to determine if the injection is occurring at the target location and / or the correct tissue and to modify the injection technique accordingly. Additionally, measurements may be recorded for later review and documentation of the clinical event.

[0048] It is contemplated to use multiple syringes driven by separate syringe plungers to deliver multiple drugs, and to use a second syringe driver that does not require reaching a predetermined pressure for this purpose, which can be programmed to specific flow rates that allow injection of local anesthesia and other therapeutic agents into various tissues.

[0049] In yet another embodiment, the device can include two independent syringe drives, both of which are hydraulically adjustable as described herein above.

[0050] Calculating the fluid pressure at the needle outlet As described above, hydraulic pressure can be used to control the operation of the system 10. For example, if the hydraulic pressure exceeds a predetermined threshold, the system can provide a signal to the operator indicating that the needle has been placed against or within dense tissue, such as the dura. There are several ways to calculate the hydraulic pressure at the needle outlet.

[0051] A pressure sensor can detect the fluid pressure in the injection assembly 20. For example, as described above, the pressure sensor can be an in-line pressure sensor. Alternatively, a pressure sensor built into the driver 50 can detect the fluid pressure between a conduit, such as the tube 22, and a fluid reservoir, such as the syringe 18, a liquid-filled carpule, or other fluid reservoir. Similarly, a pressure sensor can be located between the syringe tube 22 and the needle 24. Additionally, the in-line sensor can be incorporated inside a hub connected to the needle or between the tube 22 and the hub. In another alternative, a pressure pad force sensor is used to detect the force driving the plunger 19 and calculate the pressure in the syringe 18. A command signal from the pressure sensor sends pressure data to a CPU, which performs calculations to determine the outlet pressure. The outlet pressure value is used to control a motor 70 that controls the flow of fluid from the syringe 18.

[0052] The system is configured to provide one or more visual signals for a user to observe and / or analyze the detected pressure signal. For example, referring to Figures 1-4A, the system 10 includes a display screen 30 that displays data related to the operation of the system, including, but not limited to, pressure and flow data. For example, as shown in Figures 4A-4C, the system includes a primary pressure graph 32 on the display screen. The primary pressure graph 32 is a graph of fluid pressure versus time, which provides a graphical representation of changes in the detected fluid pressure over a period of time. The graph provides general pressure trend information, and in this embodiment, the controller processes the signal received from the pressure sensing element to remove signal changes that are not generated by the fluid pressure. For example, the controller 30 can be programmed to process the pressure data to remove pressure signal changes caused by motor operation, syringe static friction, and general pressure signal changes caused by tubing bending and needle tip height variations. Higher frequency signal changes and noise are removed using a low pass filter implemented electronically or by software. As shown in Figures 1 and 2, the screen also includes a current pressure display 38 that displays the most recent detected fluid pressure.

[0053] Display device 30 further includes a pulsatile waveform detection display 34. As described below, it is desirable to analyze the hydraulic data to detect the presence of a pulsatile waveform. As described below, the controller is configured to process the data in a manner that separates the pulsatile waveform from potential hydraulic pressures within the needle environment. Pulsatile waveform display 34 presents such processed data so that an operator can determine whether the data indicates the presence of a pulsatile waveform. As described below, pulsatile waveform display 34 includes amplitude ranges identified as elements 36.

[0054] As mentioned above, it is desirable to analyze the hydraulic data to detect the presence of pulsatile waveforms in the pressure data detected by a pressure sensor such as sensor 20. In fluid dynamics, flow with periodic fluctuations is known as pulsatile flow. Pulsatile flow is an inherent property of the cardiovascular system. In other words, the cardiovascular system produces pulsatile flow by a basic mechanism: when the ventricles contract and create the required pressure gradient, a given volume of blood is rapidly discharged into the arterial vessels. The aorta and arteries offer less resistance to blood flow than smaller vessels such as arterioles and capillaries. Because blood flows more slowly through the arterioles, the arteries expand to accommodate the extra volume of blood. During diastole, the elastic contraction of the arteries forces blood to flow and enter the arterioles. Thus, the elastic force of the arteries helps convert the pulsatile flow of blood from the heart into a more constant flow of blood through the rest of the blood circulation.

[0055] Additionally, intravascular pulsatile waveforms produced by the cardiovascular system produce corresponding extravascular pulsatile waveforms caused by the movement of blood vessels such as arteries. For example, arteries in the nerve bundles of the spinal cord produce pulsatile waveforms observed in the cerebrospinal fluid in the epidural space. The frequency of the extravascular pulsatile waveform is similar to the frequency of the intravascular pulsatile waveform, but the magnitude of the extravascular pulsatile waveform is much smaller than the magnitude of the intravascular pulsatile waveform. In particular, whereas intravascular pulsatile waveforms are caused directly by blood pressure, extravascular pulsatile waveforms are caused by the movement of blood vessels in response to blood pressure.

[0056] To identify the pulsatile waveform, the data is processed such that the data representing the pulsatile waveform is isolated. The magnitude of the background fluid pressure can make it difficult to identify the pulsatile waveform. For example, the amplitude of the pulsatile waveform may be an order of magnitude smaller than the background fluid pressure, and if the needle is placed in dense tissue, the amplitude of the pressure change resulting from the pulsatile waveform may be only 10 mmHg while the detected fluid pressure is over 100 mmHg. In such a case, the pressure may only vary from 95 mmHg to 105 mmHg, which is imperceptible on a pressure versus time graph. Therefore, it is desirable to separate the pulsatile waveform from the latent pressure. Here, the latent or background pressure refers to the pressure that results primarily from the density of the tissue in which the needle tip is placed.

[0057] To isolate the data representing the pulsatile waveform, the control device may include a self-centering filter that keeps the waveform in the center of the graph on the pulsatile waveform detection display 34. Various types of filters can be implemented to remove the average value. These filters can be constructed using mechanical, electrical, or software design. In this embodiment, a moving average filter is designed in the software programmed in the control device, which generates an average value of the pressure, which is subtracted from the current pressure measurement to generate the graph. This keeps the pulsatile waveform in the center on the graph. For example, the data is located on a reference line between the upper and lower limits of the pulsatile waveform. In one embodiment, the pressure data is processed as follows: First, an average pressure value is calculated based on the pressure values ​​detected by the sensor during a previous period, such as a period between 2 and 10 seconds. The calculated average value is then subtracted from the current pressure, and the subtracted value is displayed by the system on the pulsatile waveform detection display 34. Large pressure transients will clip the plotted graph on the pulsatile waveform detection display 34, but the average value will be centered on the detection display.

[0058] The amplitude of the pulsatile waveform may vary depending on the circumstances, and the fluid pressure at which the pulsatile waveform becomes prominent may also vary. As explained above, the controller is configured to process the data from the pressure sensor to isolate the pulsatile waveform. The controller is also configured to process the data from the pressure sensor to attempt to keep the pulsatile waveform centered on the pulsatile waveform detection display 34. While attempting to keep the pulsatile waveform centered improves the likelihood of identifying the waveform, it is possible that the waveform may be overlooked in many cases. For example, Figures 4A-4D show how the amplitude scale on the pulsatile detection display contributes to the determination of pulsatile detection. In particular, in Figure 4A, the display shows processed pressure data with an amplitude scaling of 5 mm Hg (2.5 above and below the baseline). As can be seen in Figure 4A, the pulsatile waveform is easily identifiable at this scale. Referring to Figure 4B, the amplitude range 36 is twice that of Figure 4A. Thus, the vibrations are significantly reduced but still visible. In Figure 4C, the amplitude range is doubled again, and the vibrations are small but identifiable. In Figure 4D, the amplitude range is doubled again, and the pulsatile waveform is not discernible at the scale of Figure 4D. Thus, if the operator were to begin detection using the expanded amplitude range 36 as shown in Figure 4D, the pulsatile waveform would appear not to be detected by the sensor 20.

[0059] In contrast, Figures 5A and 5B illustrate the opposite problem. In Figure 5A, data is plotted with an amplitude range 36 of 10 mm Hg. However, because the range of pressure data is greater than 10 mm Hg, many of the data points are off scale. Referring to Figure 5B, the same data is plotted with an amplitude range of 40 mm Hg. This amplitude range is large enough to fit all of the pressure data, so a pulsatile waveform is identifiable in Figure 5B.

[0060] Since there is a large variability in the amplitude range for a given set of pressure data, the system may include an option to easily scale and change the amplitude range. In particular, the system 10 includes the ability to easily perform a re-graphing of the processed pressure data in response to an operator selecting or inputting a change in the amplitude range. Such a request may be entered using any of a number of input mechanisms, including, but not limited to, a mouse, a foot switch, voice activation, a keyboard, buttons on the actuator 50, or a touch screen, and may even be entered by the software automatically cycling through different amplitude ranges. In this embodiment, the display 30 is a touch screen that includes buttons that allow the operator to toggle between any of the various amplitude ranges. If the user selects a different amplitude range, the system will re-graph the data. In this manner, the operator may manipulate the pressure data to identify whether a pulsatile waveform is present.

[0061] Noise Compensation As described above, the system 10 is configured to continuously inject liquid through the needle while the system or an operator analyzes the pressure data to detect the presence of a pulsatile waveform. However, the injection of liquid can cause disturbances that can affect the detection of the pulsatile waveform. For example, turbulence resulting from the liquid flow and static friction of the rubber / elastomer piston in the syringe are two variables that can adversely affect the detection of the pulsatile waveform. The system can be configured to isolate the pulsatile waveform from the effects of such disturbances to overcome potential problems caused by such disturbances.

[0062] The system includes a step of evaluating the configuration of the system and disturbances caused by the injection of fluid to isolate the pulsatile waveform. In certain embodiments, the system includes a noise cancellation mode. A user selects the noise cancellation mode before inserting the needle into the patient. The system then activates the driver to inject fluid through the needle. The system monitors all pressure changes that occur during the execution of the noise cancellation mode. Additionally, the system modifies the detected pressure data based on data collected during the execution of the noise cancellation mode when evaluating the presence of a pulsatile waveform.

[0063] System Control The system includes a user operable input mechanism that allows the operator to provide input signals to control the system. The input mechanism may be any of a variety of devices such as a touch screen, buttons on the actuator, or a foot control that provides a means for the operator to start, stop, and change the single flow rate from the single flow rate to a second or third pre-set different flow rate. Alternatively, the input element may be a mouse, keyboard, or a microphone that provides voice input commands. Additionally, the system may include multiple input mechanisms that allow the operator to input various inputs at various stages of the procedure. For example, the system may include a first input mechanism such as a foot pedal that controls the flow of fluid through the device. Activating (i.e., pressing) a switch on the foot pedal sends a signal to the actuator CPU, which in turn sends a signal to the motor to drive the motor, causing fluid to flow from the syringe to the needle 24 as long as the pedal is activated. Alternatively, the foot pedal may be initially activated to activate a start signal to start the flow of fluid, which continues until the operator activates the foot pedal again. In this manner, the second actuation acts as a stop signal to discontinue the flow of liquid.

[0064] As explained above, the system is operable to control the flow of fluid during treatment. In addition to utilizing an actuator for on / off control, the system can provide two or more flow rate settings. In particular, the drive unit 50 can incorporate a multi-speed pump that provides variable flow rates. Similarly, the pump can include two or more pre-set flow rates. In this embodiment, the controller 50 includes an electric motor 70 that controls the speed at which the controller moves a plunger within the syringe 18. The controller 50 can control the speed of the motor 70 to drive the motor 70 at multiple pre-set speeds to provide multiple pre-set flow rates. Different flow rates can be used at different stages of treatment, along with different pressure settings and / or other characteristics.

[0065] The switching between the multiple presets may be manual or automatic, for example, an operator may operate an input device such as a keyboard, touchpad, or other device as described above, or alternatively, the system may automatically switch to the second preset based on a detection criterion such as fluid pressure.

[0066] How it works An exemplary method of using the above system to guide a needle to a target location is described below. It should be understood that the system is not limited to use in guiding needles for drug injection. Thus, it should be understood that the principles and methods described below are readily adaptable to the insertion of needles into tissues and anatomical regions for a variety of applications and procedures.

[0067] When the needle is adjacent to a fluid or blood vessel that produces a pulsatile waveform, the processed pressure data forms an oscillating wave, such as a sine wave. Detection of the pulsatile waveform serves as a primary indicator that the needle is placed against or adjacent to the target tissue. Alternatively, detection of the pulsatile waveform serves to verify or validate that an alternative method for identifying the target tissue (such as loss of resistance) is accurate. In this manner, detection of the pulsatile waveform may be performed in combination with another probing method to improve the probability of proper needle placement while reducing accidental needle / anesthesia damage. In the following example, the system is used in combination with loss of resistance to identify the target tissue.

[0068] First, the operator determines that the target tissue is one that produces pulsatile waveforms. After such a determination is made or confirmed, the operator advances the needle into the patient's body, preferably while fluid flows through the needle 24 at a set rate. In a method in which a driver is utilized, a fluid reservoir, such as a syringe, is mounted in the driver 50. The driver then precisely controls the position of the drive element 58 to precisely control the flow of fluid from the syringe. The pressure sensor 20 detects the fluid pressure in the needle, which changes as the needle advances into different types of tissue, as shown in FIG. 4A. The changes in fluid pressure guide the direction of needle advancement during exploration of the target tissue. For example, the system can provide a perceptible output to guide the operator. In one example, the system provides an audible sound representative of pressure. For example, the audible signal may be higher pitched as pressure increases and lower pitched as pressure decreases. Similarly, the system can provide a visual signal representative of pressure changes. For example, as shown in Figure 4A, graph 32 visually depicts fluid pressure. Graph 32 depicts pressure as it changes over time. In Figure 4A, an apparent loss of resistance appears to occur at about 2840 seconds. However, a true loss of resistance occurs at about 2860 seconds. As described below, the system can be used to verify when the apparent loss of resistance is a true loss of resistance.

[0069] As described above, when the needle 24 is advanced or withdrawn, the fluid flow changes as it passes through different types of tissue. Conversely, when the needle is maintained at a particular position, the fluid pressure tends to stabilize and remain substantially constant. However, when the tip of the needle is maintained at a substantially constant position, the sensor can detect pressure changes caused by the pulsatile waveform. In particular, when the needle is maintained at a particular position relative to the target area and the particular position is adjacent to an artery, the system detects periodic changes in the detected fluid pressure. Furthermore, in addition to detecting periodic changes, the magnitude of the detected fluid pressure also serves as a guide to the user. For example, if the system detects a pressure profile having periodic pressure changes, the needle may be adjacent to an artery. However, if the fluid pressure increases and the amplitude of the pressure changes exceeds a predetermined threshold, the system determines that the needle is in the artery rather than adjacent to the artery. For example, a pressure curve showing periodic changes from 80mm / Hg to 120mm / Hg indicates that the needle is in the artery rather than adjacent to the artery.

[0070] In this manner, the system allows for the combination of detection of periodic changes in fluid pressure with a second characteristic of the fluid pressure, such as loss of resistance, as described above. For example, the system monitors the fluid pressure to guide the operator toward a target tissue, such as the epidural space, while the operator advances the needle. When the system detects a drop in pressure, indicative of loss of resistance, the system indicates that the needle is in the epidural space. In response to this determination, the system provides a signal to the user indicating that the needle is located in the target tissue, such that the user maintains the needle in that particular position. To verify that the needle is in the epidural space, the system monitors the fluid pressure to determine that there is a periodic change in the detected fluid pressure. If the system detects a periodic change in the fluid pressure indicative of a pulsatile waveform, such detection verifies that the needle is located in the epidural space. By verifying that the needle is located adjacent to or within the target tissue, a drug can be safely injected through the needle to the target tissue location in the patient.

[0071] The above describes the system automatically detecting the presence of a pulsatile waveform to verify needle placement determination. In addition to automatically detecting the presence of a pulsatile waveform, the system 10 may alternatively be configured to display hydraulic data in a manner that allows the operator to easily determine that the needle is detecting a pulsatile waveform.

[0072] In the above-described method, the operator uses continuous feedback on the fluid pressure detected at the needle to guide the needle and place it adjacent to the target tissue. One such method for guiding the needle is the loss of resistance method, which locates the target tissue adjacent to a tight barrier tissue. Once the barrier tissue is penetrated, the fluid pressure drops rapidly, indicating that the needle is properly placed in the target space. The system then processes the pressure data to attempt to detect a pulsatile waveform to verify needle placement. Detection of the pulsatile waveform serves as a verification of needle placement.

[0073] While the above examples show the use of the present system in conjunction with a loss of resistance process to place a needle at a particular location, various processes can be used to place the needle at a target location, so long as the target location is adjacent to tissue that produces a pulsatile waveform. For example, the present system can be used in conjunction with a peripheral nerve block system to verify or demonstrate proper needle placement, as described below.

[0074] In a peripheral nerve block procedure, the target tissue is a nerve associated with a neurovascular bundle. When an anesthetic is injected adjacent to the nerve, the anesthetic provides adequate anesthesia. However, when a needle is placed inside the nerve, the anesthetic may cause damage to the nerve. Therefore, a peripheral nerve block procedure may utilize electrical stimulation to guide the needle. The level of stimulation to guide the needle to the target location may be variable. The operator advances the needle and applies electrical stimulation to the tissue from the tip of the needle. If a response to the electrical stimulation is observed, the needle is considered to be adjacent to the target nerve. Additionally, fluid pressure adjacent the tip of the needle may be monitored during a peripheral nerve block procedure, as described in International Patent Application No. PCT / US2018 / 31096, published as WO 2018 / 204789 on November 8, 2018. The disclosure of International Patent Application No. PCT / US2018 / 31096, published as WO 2018 / 204789, is incorporated herein by reference in its entirety. In such a process, a combination of hydraulic pressure and electrical stimulation may be used to guide the needle to the target location. After the peripheral nerve block process is used to place the tip of the needle at the target location, detection of the pulsatile waveform is then used to verify or validate the needle placement. In particular, once the needle is placed at the planned location, it is maintained at the planned location without significant movement. While the needle is held in a fixed position, the system continues to monitor the pressure signal from the sensor 20. The data is processed to separate the pressure data from background pressure and identify the presence of a pulsatile waveform. If a pulsatile waveform is present, the determination regarding the needle's location is verified. The operator then performs a subsequent process on the target location. This subsequent process may be a medical procedure or the injection of a drug or anesthesia. Alternatively, if the peripheral nerve block process places the needle in a location believed to be the target tissue, and no pulsatile waveform is detected, the operator determines that the needle is not properly placed adjacent the target tissue and resumes the needle placement process.

[0075] From the above description, it can be seen that the present invention can incorporate one or more of a variety of probing techniques configured to identify or verify that a needle is positioned relative to or within a target tissue. For example, in the following description, the system is used to verify needle placement, but it should be understood that the system can be used to verify or verify the placement of conduits other than needles. One such example is a catheter. Often, the catheter can be inserted using any of a variety of techniques, such as the loss of resistance technique described above. After the needle is properly positioned, the catheter is inserted into the patient so that it is positioned relative to or within the target tissue. The catheter may need to be retained in the patient for an extended period of time during which the catheter may accidentally move away from the target tissue. In a current method of verifying catheter placement, a liquid, such as a drug, is injected into the patient and it is determined whether the drug is having the intended effect. If the drug is having the intended effect on the patient, the catheter is deemed to be properly positioned. If not, the search is resumed. However, the system can be used to verify or verify catheter placement. The system may include a hub configured to form a fluid-tight seal against the hub of the catheter in place of the needle 24. The hub of the system is interconnected with the hub of the catheter to form a fluid-tight seal. A driver then injects fluid from a syringe into the hub, which is then injected into the catheter until the catheter is substantially filled with fluid. The system then detects fluid within the catheter. If the pressure signal includes a pulsatile waveform, the operator verifies or demonstrates that the catheter is still properly positioned and fluid can be injected through the catheter. Conversely, if no pulsatile waveform is detected through the catheter, the operator determines that the catheter is not properly positioned and may be repositioned.

[0076] In the above examples, detection of the pulsatile waveform is utilized as a signal to verify or validate the needle or other conduit after it has been placed. Additionally, detection of the pulsatile waveform can be used as primary data to guide the placement of the needle or other conduit. According to one embodiment, a needle is inserted into a patient's body toward a target tissue. As the needle advances toward the target tissue, the amplitude of the pulsatile waveform increases. Thus, an operator determines that the needle is within a region that includes the target tissue by first monitoring for the presence of the pulsatile waveform. As the needle approaches the target tissue, the amplitude of the pulsatile waveform increases. In this manner, the change in the pulsatile waveform is utilized to guide the needle toward the target tissue.

[0077] The system is particularly configured to guide the placement of the needle or other conduit based on two characteristics. The first characteristic is a pressure range determined by the resistance of the tissue to a constant flow rate, which generates a first characteristic response to that flow rate. That is, a constant flow of fluid is injected through the needle and the sensor detects the pressure range of the fluid inside the needle when the needle is in a particular tissue. The second characteristic is determined based on pressure data received by the sensor while the needle is held in a stationary position where no fluid is injected through the needle from a fluid reservoir. The second characteristic is based on the presence of a pulsatile waveform. In particular, the second characteristic is the amplitude of the pulsatile waveform. The system is configured to allow the operator to alternate between a) translational movement during needle insertion with fluid flow through the needle and b) stationary placement of the needle without fluid flow. Comparing the amplitude of the pulsatile pressure waveform between two or more different positions provides the relative distance of the needle tip to the target. When the needle translation is stopped and maintained in a stationary position, the second characteristic is again recorded. Modifying and varying the scale 36 of the pulsatile pressure waveform graph 34 aids in comparing the amplitude height of the pulsatile waveform between two or more time points, thereby allowing visualization of the amplitude height of the vibration waveform. Comparing the amplitude height of the pressure waveform between two or more different time points provides information for determining the relative position of the needle tip to the target tissue. For example, if the amplitude of the subsequent pressure waveform is smaller than the preceding pressure waveform, the needle is moving away from the target tissue. Conversely, if the amplitude of the subsequent pressure waveform is larger than the preceding pressure waveform, the needle is moving towards the target. And, if the amplitude of the pressure waveform does not change significantly between the two time points, the relative distance of the needle tip to the target tissue has not changed. It should be understood that the apparatus can change the amplitude scale during the above steps to identify pressure waveforms of varying intensity. Thus, by identifying a particular space or tissue using a first feature and then utilizing a second feature with varying amplitude, objective data is provided regarding the directionality of the needle within the tissue, and these two different features form the basis for determining the needle's guidance to the target tissue.

[0078] One example of using the amplitude of the pulsatile waveform as feedback for needle placement is in dental applications. The method includes setting a specific measurement scale on the pulsatile waveform grab 34 and observing the pulsatile waveform at a given distance in the center of the grab 34. As the operator advances the needle toward the intended target, an increase in amplitude is observed during intermittent pauses in needle advancement and while drug is being injected. This provides a guide for guiding the movement of the needle tip to allow for administration of anesthetic fluid in proximity to the neurovascular bundle of the inferior alveolar plexus. The system is used in conjunction with a dental instrument that includes an LED screen, such as a display 34, that displays a graph of the pulsatile waveform. Additionally, instead of using an in-line single-use sensor, a non-in-line reusable sensor can be incorporated into the system. For example, the injection assembly may include a fluid line with a flexible sidewall. A clamshell-type sensor engages the outer wall of the tube such that the flexible sidewall is positioned between the sensor halves. The sensor detects radially outward pressure, which represents the fluid pressure in the tubing, and thus the fluid pressure inside the needle. In this way, the clamshell sensor serves as an alternative to the in-line pressure sensor described above in connection with the epidural space system. The clamshell piezoelectric sensor allows the tubing to be placed inside the clamshell to detect in-line fluid pressure.

[0079] The system 10 can also be incorporated into the process of placing a needle or other conduit to confirm placement of the subarachnoid needle in the cerebrospinal fluid. The system can be used in conjunction with the loss of resistance method described above to guide the needle to the proper location, which is then stopped at the determined location. The system processes the hydraulic data while needle movement is stopped. If a pulsatile waveform is detected, the operator determines that the needle has been properly placed in the cerebrospinal fluid.

[0080] Additionally, the system can be incorporated into other procedures to determine if a needle or other element is properly placed. One such application is a cardiovascular application, in which the system is used to determine if a needle or catheter is placed in the lumen of a blood vessel by measuring absolute pressure in addition to detecting the presence of a pulsatile waveform. This determines vascular patency during placement of vascular stents and / or ablation of cardiac tissue during which therapeutic agents are delivered or diagnostic procedures to determine the patency of the cardiovascular system are performed. Detection of the pulsatile waveform along with absolute pressure measurements provides diagnostic information during these procedures.

[0081] Yet another application of the system 10 relates to drug infusion pumps. In the embodiment described above, the system utilizes a syringe pump to infuse liquid into a patient. However, the improved system may also be incorporated into an infusion pump system, including a peristaltic pump system with a closed drug delivery system consisting of a drive, tubing, and an indwelling catheter in the patient's vein. The system operates by intermittently stopping the motor, which allows for detection of a pulsatile waveform to ensure that the catheter has not moved from its home position within the patient's body. In this manner, the system provides a process for determining the placement location and relative patency of the catheter while it is in use.

[0082] Those skilled in the art will recognize that changes or modifications may be made to the above-described embodiments without departing from the broad and inventive concept of the present invention. For example, although the system has been described above in the context of performing liquid injection, the system may be used to aspirate liquid-filled tissue, or to place a needle for removal of target tissue, such as to perform a biopsy. It is therefore to be understood that the present invention is not limited to the specific embodiments described herein, but is intended to include all changes and modifications within the scope and spirit of the invention as set forth in the appended claims.

Claims

1. 1. A device for administering a liquid to a target location within a patient's body, the device comprising: An injection assembly (20) comprising: (a) a liquid reservoir, which is the barrel (18) of a syringe that stores liquid to be delivered to the needle (24); (b) a discharge element which is a plunger (19) movable relative to the liquid reservoir to expel liquid from the liquid reservoir; (c) a sensor (20) for detecting a characteristic indicative of fluid pressure within the needle, the sensor being configured to detect the characteristic continuously while the device including the needle is inserted into the subject's body; and (d) a flexible conduit (22) in fluid communication with the fluid reservoir and the sensor, the flexible conduit being configured to have a rigidity such that it will not radially expand under a pressure of less than 500 mm / Hg; and wherein the injection assembly comprises: The needle device further comprises: (e) a display screen (62) for displaying data related to the operation of the device including the needle, including the fluid pressure at the needle outlet, and displaying a pulsatile waveform; (f) a drive unit (50), (i) a drive element (58) including a motor (70) and configured to engage and control movement of the dispensing element; (ii) a controller (30) operable to control the drive element to control fluid flow from the fluid reservoir to the needle, the controller being configured to periodically interrupt operation of the drive element and to process data from the sensor to detect one or more features indicative of a pulsatile waveform; and having the device is configured such that, in use, the volume of fluid between the needle and the fluid reservoir is constant, such that when the actuation of the drive element is stopped, the sensor can accurately detect a pulsatile waveform passing through the residual fluid inside the needle; the driver precisely controls the position of the plunger relative to the syringe barrel to precisely control the volume of fluid in the syringe barrel, and the driver acts as a stop to prevent relative movement of the plunger relative to the syringe barrel when the motor is stopped, by maintaining the plunger in a fixed position against forward or backward movement of the plunger to block or prevent movement of the plunger due to fluid back pressure, and the above configuration of the injection assembly and driver prevents fluid volume changes that could affect detection of a pulsatile waveform. A device with a needle.

2. 10. The needle device of claim 1, wherein the controller is configured to analyze data from the sensor to detect one or more characteristics indicative of loss of resistance.

3. A device with a needle as described in claim 2, wherein the control device is configured to interrupt operation of the drive element in response to detection of one or more features indicative of loss of resistance, and to process data from the sensor to detect one or more features indicative of a pulsatile waveform.

4. A device with a needle as described in claim 3, wherein the control device is configured to provide a verification signal indicating that the needle is properly positioned adjacent to the target tissue when a signal representing loss of resistance and a signal representing the presence of a pulsatile waveform are received at the needle.

5. 2. The needle device of claim 1, wherein the display screen has a first output configured to display fluid pressure in the needle as a function of time in a manner consistent with a loss of resistance guidance procedure.

6. A device having a needle as described in any one of claims 1 to 5, wherein the control device is configured to process data from the sensor to separate data representing a pulsatile waveform.

7. A device with a needle as described in claim 5, wherein the display screen has a second output configured to display data representing the pulsatile waveform while the first output displays fluid pressure as a function of time on the output.

Citation Information

Patent Citations

  • Pharmaceutical Injection Device for Identification of Central and Peripheral Nerve Tissue Using Injection Pressure Sensing

    JP2009504316A

  • Method and apparatus for subcutaneous injection using electrical nerve stimulation

    JP2018531098A

  • Spinal canal access and probe positioning, devices and methods

    US20150025363A1

  • Automated drug delivery systems and methods

    WO2018022955A1